University of Pittsburgh Cancer Institute (UPCI)

Clinical Research

Clinical Research Overview

In collaboration with UPMC CancerCenter and with support from UPCI Clinical Research Services (CRS), UPCI investigators are leading innovative clinical trials that offer patients access to the latest cancer tests and treatments. Before clinical trials can become active, they must be approved by the UPCI Protocol Review Committee (PRC). UPCI's Data and Safety Monitoring Committee (DSMC) provides oversight for and ensures the safety of participants in clinical trials.

Click on the links below to learn more about UPCI disease-oriented areas of cancer research.

* indicates programs that are currently supported by the NCI Cancer Center Support Grant to UPCI.